Chapter 2: Cancer Survillience and Data
Better Cancer Data, Better Health for All Californians
High-quality, inclusive cancer data are critical to reducing disparities and improving outcomes across all populations. Enhancing the California Cancer Registry (CCR) to include detailed information on race, ethnicity, language, gender identity, sexual orientation, disability status, and social determinants of health helps identify at-risk populations who are currently invisible in the cancer data continuum, and guide more effective interventions to reduce inequities. Special emphasis is placed on historically underrepresented groups, including Latinx, Indigenous, African American, Asian American, Native Hawaiian, and Pacific Islander (AANHPI) communities, as well as children and Lesbian Gay Bisexual Transgender Queer and more (LGBTQ+) populations.
Expanding demographic data collection improves completeness and relevance, helping identify service gaps and support equitable resource allocation. Bolstering the collection of Sexual Orientation, Gender Identity, and related data (SOGI+) ensures LGBTQ+ populations are accurately represented in research, clinical practice, and health policy.
To support an integrated public health infrastructure, efforts are underway to reduce data fragmentation by linking CCR data with complementary sources such as health surveys, vital records, and medical claims. These linkages enable a more nuanced understanding of how socioeconomic factors—such as income, education, and geography—influence cancer risk and access to care. Investments in data quality and usability include developing interactive dashboards and analytical tools that empower researchers, community organizations, and policymakers to translate data into actionable insights.
The goal is clear: build a modern, comprehensive cancer data system that reflects California's diversity and supports equitable access across the patient care continuum. Improving data quality and inclusive representation lays the foundation for smarter policies, targeted interventions, expanded research opportunities, and stronger outcomes—ensuring every community benefits from high-quality cancer care.